NCT05617755: AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients with Platinum Resistant Epithelial Ovarian Cancer |
|
|
| Active, not recruiting | 1 | 19 | US | AB-1015, Integrated Circuit T (ICT) cells | Arsenal Biosciences, Inc. | Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Genital Neoplasm, Female, Abdominal Neoplasm, Recurrence | 09/24 | 02/27 | | |
